Amgros open to the idea of pricing antibiotics in new ways: "But the Danish market will hardly make a big difference"

The industry calls for new methods of paying for innovative antibiotics to fight resistant bacteria, and the supplier Amgros is open to looking at the possibilities, according to CEO Flemming Sonne.

Photo: Anne-Li Engström / Amgros / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles